These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 12514092)

  • 1. Immunohistochemical detection of the retinoid X receptors alpha, beta, and gamma in human prostate.
    Alfaro JM; Fraile B; Lobo MV; Royuela M; Paniagua R; Arenas MI
    J Androl; 2003; 24(1):113-9. PubMed ID: 12514092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of nuclear retinoid receptors in normal and malignant prostates.
    Lotan Y; Xu XC; Shalev M; Lotan R; Williams R; Wheeler TM; Thompson TC; Kadmon D
    J Clin Oncol; 2000 Jan; 18(1):116-21. PubMed ID: 10623701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
    Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
    J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoexpressions of p21, Rb, mcl-1 and bad gene products in normal, hyperplastic and carcinomatous human prostates.
    Royuela M; Arenas MI; Bethencourt FR; Sánchez-Chapado M; Fraile B; Paniagua R
    Eur Cytokine Netw; 2001; 12(4):654-63. PubMed ID: 11781193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive expression analysis of retinoic acid receptors and retinoid X receptors in non-small cell lung cancer: implications for tumor development and prognosis.
    Brabender J; Metzger R; Salonga D; Danenberg KD; Danenberg PV; Hölscher AH; Schneider PM
    Carcinogenesis; 2005 Mar; 26(3):525-30. PubMed ID: 15618235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasia.
    Monsef N; Soller M; Isaksson M; Abrahamsson PA; Panagopoulos I
    Prostate; 2009 Jun; 69(9):909-16. PubMed ID: 19274762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of retinoid receptors in sebaceous cell carcinoma.
    Chakravarti N; El-Naggar AK; Lotan R; Anderson J; Diwan AH; Saadati HG; Diba R; Prieto VG; Esmaeli B
    J Cutan Pathol; 2006 Jan; 33(1):10-7. PubMed ID: 16441406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoreactivity of ubiquitin in human prostate gland.
    Bataineh ZM; Habbal O
    Neuro Endocrinol Lett; 2006 Aug; 27(4):517-22. PubMed ID: 16892003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberration in the expression of the retinoid receptor, RXRalpha, in prostate cancer.
    Zhong C; Yang S; Huang J; Cohen MB; Roy-Burman P
    Cancer Biol Ther; 2003; 2(2):179-84. PubMed ID: 12750559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical localization of the retinoic Acid receptors in human prostate.
    Richter F; Joyce A; Fromowitz F; Wang S; Watson J; Watson R; Irwin RJ; Huang HF
    J Androl; 2002; 23(6):830-8. PubMed ID: 12399530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma.
    Ricote M; García-Tuñón I; Bethencourt FR; Fraile B; Paniagua R; Royuela M
    Cancer; 2004 Apr; 100(7):1388-96. PubMed ID: 15042672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and cellular localization of follicle-stimulating hormone receptor in normal human prostate, benign prostatic hyperplasia and prostate cancer.
    Mariani S; Salvatori L; Basciani S; Arizzi M; Franco G; Petrangeli E; Spera G; Gnessi L
    J Urol; 2006 Jun; 175(6):2072-7; discussion 2077. PubMed ID: 16697805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and significance of granulocyte-macrophage colony-stimulating factor receptors in human prostate cancer].
    Chen Z; Yang Y; Xiao Y; Zhao J
    Zhonghua Nan Ke Xue; 2004 Sep; 10(9):655-7. PubMed ID: 15497703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p38 transduction pathway in prostatic neoplasia.
    Ricote M; García-Tuñón I; Bethencourt F; Fraile B; Onsurbe P; Paniagua R; Royuela M
    J Pathol; 2006 Feb; 208(3):401-7. PubMed ID: 16369914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of c-jun oncogene in hyperplastic and carcinomatous human prostate.
    Tiniakos DG; Mitropoulos D; Kyroudi-Voulgari A; Soura K; Kittas C
    Urology; 2006 Jan; 67(1):204-8. PubMed ID: 16413376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-inflammatory cytokines and prostate-specific antigen in hyperplasia and human prostate cancer.
    Bouraoui Y; Ricote M; García-Tuñón I; Rodriguez-Berriguete G; Touffehi M; Rais NB; Fraile B; Paniagua R; Oueslati R; Royuela M
    Cancer Detect Prev; 2008; 32(1):23-32. PubMed ID: 18400418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic characterization of the infiltrating immune cells in normal prostate, benign nodular prostatic hyperplasia and prostatic adenocarcinoma.
    Hussein MR; Al-Assiri M; Musalam AO
    Exp Mol Pathol; 2009 Apr; 86(2):108-13. PubMed ID: 19111537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metallothionein expression in human prostate gland.
    Bataineh ZM; Nusier MK
    Saudi Med J; 2003 Nov; 24(11):1246-9. PubMed ID: 14647563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal cell hyperplasia in the peripheral zone of the prostate.
    Thorson P; Swanson PE; Vollmer RT; Humphrey PA
    Mod Pathol; 2003 Jun; 16(6):598-606. PubMed ID: 12808066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.